A Unified Metric of Human Immune Health?
Baird T. and Sansom SN., (2025), Transplantation, 109, 1269 - 1270
IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy.
Imianowski CJ. et al, (2024), Cancer Res Commun, 4, 2045 - 2057
GS-TCGA: Gene Set-Based Analysis of The Cancer Genome Atlas.
Baird T. and Roychoudhuri R., (2024), J Comput Biol, 31, 229 - 240
Identifying employee, workplace and population characteristics associated with COVID-19 outbreaks in the workplace: a population-based study
Overton CE. et al, (2024), Occupational and Environmental Medicine, 81, 92 - 100
Understanding the leading indicators of hospital admissions from COVID-19 across successive waves in the UK
Mellor J. et al, (2023), Epidemiology & Infection, 151, e172 - e172
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response
Willis SE. et al, (2021), British Journal of Cancer, 125, 1666 - 1676
SLFN11 informs on standard of care and novel treatments in a wide range of cancer models.
Winkler C. et al, (2021), Br J Cancer, 124, 951 - 962
Meeting Abstracts of the BACR conference: response and resistance in cancer therapy Abstracts
(2018), CANCER DRUG RESISTANCE, 1, 266 - 302